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Viral transmission between animals and humans has 
been defined as Zoonosis and zooanthroponosis. The 
vaccine has been claimed to be the best tool to prevent 
viral epidemics. However, as learned from SARS-
CoV-2, vaccines cannot be the true answer to prevent 
viral infection for everyone. Some vaccinated persons 
are still reported to get infected. Viral mutation has 
been principally postulated to explain immune evasion. 
Questionable, why the mutated viral strain does not evade 
the immunity of everyone who has been vaccinated? 
Mutated viral strains cause various symptoms, non-
symptomatic to morbidity and mortality, in different 
individuals with more or less the same ratio as the original 
SARS-CoV-2. Approximately, 25-35% of the SARS-
CoV-2 detected individuals are asymptomatic, while 15-
20% developed severity and about 2-5% have critical 
symptoms [1,2]. Logically, the viral mutation could keep 
mutating in any part of its genome. The new variant might 
maintain infectivity in the same person and might develop 
to infect another person who once has not been susceptible 
to the original strain. Thus, the dynamics of viral infection 
could change from time to time. This requires a better 
explanation to lead us in the right direction to prevent the 
emergent virus either now or in the future.
A virus is an obligated intracellular agent therefore it 
requires entering the susceptible host cell for replication. 
This is unlike most bacteria which are extracellular 
organisms and can proliferate regardless of entering into 
any cell of the infected host. Actually, the virus needs 
susceptible cellular molecule(s) to play a role as its 
receptor and co-receptor for attachment and penetration. 
Each virus uses its receptor-binding domain (RBD) 
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to bind a different cellular molecule for this process. 
For example, SARS-CoV-2 has been known to use 
angiotensin-converting enzyme 2 (ACE-2) as its receptor 
and transmembrane protease serine2 (TMPRSS2), and 
furin as its co-receptors. Many studies found that the 
cellular molecules of individuals are polymorphism 
including ACE-2, TMPRSS2, and furin. The association of 
these cellular molecule variants and the severity of SARS-
CoV-2 infection has been suggested in many studies [3-
5]. In other words, individuals must have a susceptible 
variant for viral attachment and penetration. Individuals 
who were reported to be positive with the viral genome 
do not mean that they are truly infected. They could be 
just exposed (invaded), not infected. SARS-CoV-2 has the 
ability to persist outside the cell for a week in a suitable 
condition which becomes its advantage for finding a 
susceptible host for easier transmission than other viruses.
On the other hand, like any foreign substance, a 
viral agent that is exposed to individuals could induce 
adaptive immunity to prevent and eradicate the virus. 
The major immune cells are helper T (Th) cell, cytotoxic 
T (Tc) cell, and B cell which plays a role to synthesize 
antibodies. The adaptive immunity could respond to the 
invading viruses regardless of whether the viruses cause 
infection or not. To make a story short, the induction of 
the compatible Th and Tc is dependent on the existence 
of the major histocompatibility complex (MHC) alleles 
of the individuals [6,7]. To produce effective adaptive 
immunity, individuals require compatible MHC alleles to 
induce the associated Th and Tc cell clones. Subsequently, 
Th cell clones play the essential role to promote the 
activated Tc and B cell to be the memory Tc and B cell 
for effective and long-lasting immunity. Individuals 
who have incompatible MHC alleles cannot generate 
the susceptible Th and/or Tc cell clones. Tc is a key to 
eliminating the viral infected cell while antibody plays 
a role to neutralize the viral agent for preventing its 
entry into a target cell. To produce the memory B cell 
clones that are absolutely specific to the virus’s RBD, 
the compatible Th must be activated. The memory B cell 
clones can be differentiated to be an antibody-secreting 
B cell to produce IgG and IgA which are the effective 
isotype of antibody to prevent the future invading virus [8,9]. 
Without compatible Th, the individuals can produce only 
IgM which usually is less effective and disappear sooner. 
This later group of individuals cannot produce immunity 
to prevent themselves from the future invading virus [8,9]. 
This explains why some individuals cannot prevent viral 
infection although they have been vaccinated. In addition, 
the vaccinated individuals who have been detected to be 
reactive to the SARS-CoV-2 might not be truly infected 
but invaded. It should find a suitable clinical practice to 
differentiate and handle the situation.
Many viruses, including SARS-CoV-2, do not cause 
any pathogenesis directly to the host. It is the host immune 
cells that timeously produce various kinds of cytokines 
for responding to foreign substances that invade a body 
regardless of whether they are pathogens or not. The 
side-effect of pro-inflammatory cytokines subsequently 
becomes the cause of illness to the host. In the virally 
infected hosts, the generation of the viral progeny induces 
unlimited amounts of pro-inflammatory cytokines, so-
called cytokine storms, to cause severe pathogenesis 
[10,11]. In the viral invaded host, on the other hand, the 
pro-inflammatory cytokines can also be produced but in 
a limited amount because of no production of the viral 
progeny but can still cause possible mild symptoms.
Accordingly, as shown in Table 1, it could be proposed 
Table 1. Classification of the population based on the existences of susceptible variant(s) of receptor/co-receptor of the 











cause infection and likely to show severe symptoms, however adaptive immunity should 
be able clear the viral agent within 1-2 weeks 
2 + -
cause infection without any compatible and effective immunity. High potential to  
cause mortality.
Note: to avoid false positive effectivity of the candidate drug, the study should be 
processed with only this group, not others.
3 - +
No infection (no viral replication), could be either non or mild symptomatic
can produce the entire adaptive immunity against the invaded virus 
Note: these individuals could be a good source of passive immunity for group 2.
4 - -
No infection (no viral replication), could be either non or mild symptomatic
can produce IgM antiviral antibody, but no memory B and T cells 
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to classify individuals into four groups based on their 
genetics of the cellular variants for the susceptibility to the 
viral infection and the compatible MHC alleles to produce 
the viral immunity.
Since mammal livestock have similar properties 
of cellular functions and immune systems as humans, 
based on this perspective, selective breeding cannot 
be applied in humans but could be done with mammal 
livestock. Mammal livestock breeders should have the 
characteristics as in the population group 3 and their 
MHC alleles should be heterozygous to generate more 
compatible MHC alleles for interaction to more varieties 
of the antigenic epitopes of the emergent viruses. This 
can bring sustainability to the mammal livestock industry 
worldwide. In addition, it might be a good way to prevent 
viral zoonosis. It should be noted that the characteristics 
of the breeders in group 4 should be avoided since they 
could be the source of the viral reservoir. This issue could 
be discussed at another opportunity.
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